** Shares of Orthocell OCC.AX rise as much as 5.7% to
A$0.370, set to gain most since April 5 - if current gains hold
** The biotech co reports revenue of A$1.84 million ($1.24
million) for June quarter, up 14.41% from a year earlier
** Co sees FY24 revenue of A$6.72 million, up 30.40% from
previous year
** Stock hits its highest level since July 1
** Stock is down 14.6% this year as of last close
($1 = 1.4839 Australian dollars)
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com;))